"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","22/87","87/2914",9.13434845669831e-16,4.20076115213957e-13,2.33395147269741e-13,"IKBKE/JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/TBK1/TRAF3/MAP2K1/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",22
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","22/87","90/2914",2.00354267987579e-15,4.20076115213957e-13,2.33395147269741e-13,"IKBKE/JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/TBK1/TRAF3/MAP2K1/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",22
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","22/87","90/2914",2.00354267987579e-15,4.20076115213957e-13,2.33395147269741e-13,"IKBKE/JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/TBK1/TRAF3/MAP2K1/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",22
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","41/87","397/2914",1.4702823287988e-14,1.48746488132413e-12,8.26438524976339e-13,"CSNK2A1/CSNK2B/FOXO1/JUN/MAPK1/MAPK14/MAPK8/PRKACA/RELA/RPS6KA4/RPS6KA5/SMAD3/SMAD4/STAT3/ABL1/CDON/CTNNB1/ROCK2/SPAG9/HRAS/MAP2K1/PIK3CA/RHOA/AKT1/AKT2/EGFR/GRB2/MAPK11/PAK1/PRKCA/RPS6KA2/SRC/VAV2/VAV3/KLF4/FOXO3/RARA/CREB1/SMAD2/SOX2/FLI1",41
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","14/87","30/2914",1.51842056293215e-14,1.48746488132413e-12,8.26438524976339e-13,"JUN/MAPK1/MAPK8/HRAS/MAP2K7/MAPK10/MAPK9/MAP3K1/GRB2/PAK1/SYK/VAV2/VAV3/FOS",14
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","14/87","30/2914",1.51842056293215e-14,1.48746488132413e-12,8.26438524976339e-13,"JUN/MAPK1/MAPK14/MAPK8/RPS6KA5/MAPK10/MAPK9/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",14
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","23/87","110/2914",1.65536632261827e-14,1.48746488132413e-12,8.26438524976339e-13,"IKBKE/JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/TBK1/TRAF3/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",23
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","20/87","83/2914",6.27848607146424e-14,4.93645967368876e-12,2.74270707332385e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",20
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","20/87","84/2914",8.05562868106376e-14,5.0669904403891e-12,2.81523023380333e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",20
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","20/87","84/2914",8.05562868106376e-14,5.0669904403891e-12,2.81523023380333e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",20
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","20/87","86/2914",1.31172175761976e-13,7.50066350493483e-12,4.1673839572226e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",20
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","19/87","78/2914",2.36400791288291e-13,1.06211498371668e-11,5.90113253441449e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","19/87","78/2914",2.36400791288291e-13,1.06211498371668e-11,5.90113253441449e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","19/87","78/2914",2.36400791288291e-13,1.06211498371668e-11,5.90113253441449e-12,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-450294","R-HSA-450294","MAP kinase activation","17/87","60/2914",3.3414749519756e-13,1.40119182986177e-11,7.78505041442735e-12,"JUN/MAPK1/MAPK14/MAPK8/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",17
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","23/87","127/2914",4.41677109692414e-13,1.7363431374783e-11,9.64715792222905e-12,"IKBKE/JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/TBK1/TRAF3/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/TICAM1/ATF1/FOS/CREB1",23
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","17/87","64/2914",1.08417964032707e-12,4.01146466921016e-11,2.22877796030085e-11,"JUN/MAPK1/MAPK14/MAPK8/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",17
"R-HSA-168249","R-HSA-168249","Innate Immune System","40/87","428/2914",1.19601511712598e-12,4.17940838151244e-11,2.32208782974166e-11,"BCL10/CARD9/CSNK2B/IKBKE/JUN/MAPK1/MAPK14/MAPK8/PRKACA/RELA/RIPK2/RPS6KA5/TBK1/TRAF3/ABL1/CTNNB1/HRAS/MAP2K1/PIK3CA/PRKCD/RHOA/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/PRKDC/GRB2/MAPK11/PAK1/PPP2CA/RPS6KA2/SRC/SYK/TICAM1/VAV2/VAV3/ATF1/FOS/CREB1",40
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","19/87","86/2914",1.60053659136954e-12,5.03368757985722e-11,2.79672709649836e-11,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","19/87","86/2914",1.60053659136954e-12,5.03368757985722e-11,2.79672709649836e-11,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","35/87","332/2914",1.84304720843027e-12,5.4729080195652e-11,3.04075886954338e-11,"FOXO1/JUN/MAPK1/MAPK14/MAPK8/PRKACA/RELA/RIPK2/RPS6KA5/SMAD3/STAT3/TBK1/TP53/MAP2K1/PIK3CA/AKT1/IRS1/MAP2K7/MAPK10/MAPK9/CASP3/MAPKAPK2/GRB2/MAPK11/PPP2CA/RPS6KA2/SYK/ATF1/FOS/FOXO3/CREB1/STAT5A/SOX2/IRF4/POU2F1",35
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","19/87","87/2914",2.00122232829888e-12,5.4729080195652e-11,3.04075886954338e-11,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","19/87","87/2914",2.00122232829888e-12,5.4729080195652e-11,3.04075886954338e-11,"JUN/MAPK1/MAPK14/MAPK8/RELA/RIPK2/RPS6KA5/MAP2K1/MAP2K7/MAPK10/MAPK9/MAP3K1/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/FOS/CREB1",19
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","17/87","70/2914",5.38170145639345e-12,1.41045425669645e-10,7.83651264702905e-11,"MAPK1/MAPK14/RPS6KA5/STAT3/HRAS/MAP2K1/PIK3CA/RHOA/IRS1/MAPKAPK2/GRB2/MAPK11/PPP2CA/RPS6KA2/SRC/ATF1/CREB1",17
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","8/87","10/2914",1.96068941810442e-11,4.93309457595073e-10,2.74083741815018e-10,"JUN/MAPK1/MAPK14/MAPK8/MAPK10/MAPK9/MAPK11/FOS",8
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","17/87","85/2914",1.5349870333041e-10,3.71348786133954e-09,2.06322143747758e-09,"MAPK14/PRKACA/CTNNB1/ROCK2/HRAS/PIK3CA/PRKCD/RHOA/AKT1/AKT2/MAPKAPK2/MAPK11/PAK1/PRKCA/SRC/VAV2/VAV3",17
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","17/87","87/2914",2.26869171331952e-10,5.28521143584436e-09,2.93647426441357e-09,"BCL10/JUN/MAPK1/MAPK8/RELA/HRAS/PIK3CA/MAP2K7/MAPK10/MAPK9/MAP3K1/GRB2/PAK1/SYK/VAV2/VAV3/FOS",17
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","17/87","89/2914",3.3162521230815e-10,7.44972351935094e-09,4.13908159722954e-09,"MAPK1/MAPK14/RPS6KA5/STAT3/HRAS/MAP2K1/PIK3CA/RHOA/IRS1/MAPKAPK2/GRB2/MAPK11/PPP2CA/RPS6KA2/SRC/ATF1/CREB1",17
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","17/87","92/2914",5.74738225950265e-10,1.24658739352661e-08,6.92606500963658e-09,"MAPK14/PRKACA/CTNNB1/ROCK2/HRAS/PIK3CA/PRKCD/RHOA/AKT1/AKT2/MAPKAPK2/MAPK11/PAK1/PRKCA/SRC/VAV2/VAV3",17
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","12/87","44/2914",2.25334167699486e-09,4.72450638276589e-08,2.6249453921484e-08,"JUN/MAPK1/MAPK14/MAPK8/TP53/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/FOS/E2F3",12
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","31/87","347/2914",4.28150176856881e-09,8.68730520138639e-08,4.82668450650202e-08,"MAPK1/MAPK14/PRKACA/RPS6KA5/STAT3/CTNNB1/ROCK2/HRAS/MAP2K1/PIK3CA/PRKCD/RHOA/AKT1/IRS1/AKT2/YAP1/EGFR/MAPKAPK2/GRB2/MAPK11/PAK1/PPP2CA/PRKCA/RPS6KA2/SRC/VAV2/VAV3/ATF1/ESR1/CREB1/STAT5A",31
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","9/87","24/2914",1.1266723313876e-08,2.21461530138375e-07,1.23044478296277e-07,"MAPK1/MAPK14/RPS6KA5/MAPKAPK2/MAPK11/PPP2CA/RPS6KA2/ATF1/CREB1",9
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","16/87","99/2914",1.52849937814188e-08,2.91341245106437e-07,1.61869790603861e-07,"JUN/MAPK1/MAPK14/MAPK8/RB1/RELA/STAT3/TP53/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/RPS6KA2/FOS/E2F3",16
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","22/87","201/2914",3.89832652625449e-08,7.21190407357081e-07,4.00694862760523e-07,"CSNK2A1/CSNK2B/FOXO1/JUN/MAPK1/PRKACA/TP53/PIK3CA/PRKCD/AKT1/IRS1/AKT2/EGFR/GRB2/PPP2CA/PRKCA/SRC/EGR1/ESR1/FOXO3/FOXO4/CREB1",22
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","7/87","14/2914",4.81133845677727e-08,8.64666254089401e-07,4.80410336135355e-07,"FOXO1/SMAD3/SMAD4/KLF4/FOXO3/FOXO4/SMAD2",7
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","16/87","108/2914",5.55420663816475e-08,9.70443326501563e-07,5.39180293529443e-07,"JUN/MAPK1/HRAS/PIK3CA/AKT1/AKT2/EGFR/SRC/TBP/ESR1/FOS/FOXO3/USF1/CREB1/FOXA1/POU2F1",16
"R-HSA-422475","R-HSA-422475","Axon guidance","24/87","254/2914",1.4760184590357e-07,2.50923138036069e-06,1.39413407795121e-06,"CSNK2A1/CSNK2B/MAPK1/MAPK14/MAPK8/PRKACA/RPS6KA4/RPS6KA5/ABL1/ROCK2/HRAS/MAP2K1/PIK3CA/RHOA/EGFR/GRB2/MAPK11/PAK1/PRKCA/RPS6KA2/SRC/VAV2/VAV3/CREB1",24
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","35/87","499/2914",1.87095735223335e-07,3.09692677514415e-06,1.72065883917305e-06,"CSNK2A1/CSNK2B/FOXO1/JUN/MAPK1/MAPK14/PRKACA/RB1/SIRT1/SMAD3/SMAD4/TP53/ABL1/CTNNB1/AKT1/AKT2/YAP1/EGFR/MAPK11/PPP2CA/SRC/VDR/TBP/KLF4/ESR1/FOS/FOXO3/FOXO4/MAX/RARA/CREB1/SMAD2/SOX2/TEAD4/POU2F1",35
"R-HSA-373760","R-HSA-373760","L1CAM interactions","11/87","53/2914",2.42651361606682e-07,3.91353093463085e-06,2.1743657774202e-06,"CSNK2A1/CSNK2B/MAPK1/RPS6KA4/RPS6KA5/MAP2K1/EGFR/PAK1/RPS6KA2/SRC/VAV2",11
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","34/87","481/2914",2.56705874264417e-07,4.03669987280796e-06,2.24279869094175e-06,"CSNK2A1/CSNK2B/FOXO1/JUN/MAPK1/MAPK14/PRKACA/RB1/SIRT1/SMAD3/SMAD4/TP53/ABL1/CTNNB1/AKT1/AKT2/YAP1/EGFR/MAPK11/PPP2CA/SRC/VDR/TBP/KLF4/ESR1/FOS/FOXO3/FOXO4/MAX/RARA/CREB1/SMAD2/SOX2/TEAD4",34
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","17/87","136/2914",2.6585258820739e-07,4.07856775566947e-06,2.26606057214001e-06,"JUN/MAPK1/HRAS/PIK3CA/AKT1/AKT2/EGFR/SRC/TBP/ESR1/FOS/FOXO3/RARA/USF1/CREB1/FOXA1/POU2F1",17
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","19/87","172/2914",3.47380059871352e-07,5.20242994426382e-06,2.89048069867892e-06,"CSNK2A1/CSNK2B/FOXO1/JUN/MAPK1/TP53/PIK3CA/AKT1/IRS1/AKT2/EGFR/GRB2/PPP2CA/SRC/EGR1/ESR1/FOXO3/FOXO4/CREB1",19
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","10/87","44/2914",3.60999386332119e-07,5.28066544192797e-06,2.9339485009122e-06,"HRAS/PIK3CA/PRKCD/RHOA/AKT1/AKT2/EGFR/GRB2/PRKCA/SRC",10
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","7/87","18/2914",4.04729858633556e-07,5.78579729728425e-06,3.21460079106078e-06,"MAPK1/HRAS/EGFR/GRB2/PRKCA/RPS6KA2/CREB1",7
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","7/87","20/2914",9.39024789100414e-07,1.31254798298702e-05,7.29254339137631e-06,"CSNK2A1/CSNK2B/MAPK1/MAP2K1/EGFR/PAK1/VAV2",7
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","10/87","49/2914",1.05786090228945e-06,1.44650979900013e-05,8.03683797620358e-06,"FOXO1/SIRT1/SMAD3/SMAD4/AKT1/AKT2/KLF4/FOXO3/FOXO4/SMAD2",10
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","11/87","63/2914",1.53529384125006e-06,2.05468048116232e-05,1.1415846703136e-05,"MAPK1/HRAS/PIK3CA/AKT1/AKT2/EGFR/SRC/ESR1/FOS/FOXO3/CREB1",11
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","8/87","33/2914",3.44682494861384e-06,4.51677685974605e-05,2.50953044504341e-05,"MAPK1/MAPK14/HRAS/MAP2K1/MAPKAPK2/GRB2/MAPK11/SRC",8
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","7/87","24/2914",3.80356011844228e-06,4.8825292132657e-05,2.71274319940459e-05,"MAPK1/AKT1/AKT2/EGFR/FOS/FOXO3/CREB1",7
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","22/87","268/2914",6.31777637323806e-06,7.94776267753348e-05,4.41579317034745e-05,"FOXO1/MAPK1/SMAD3/SMAD4/STAT3/CTNNB1/HRAS/MAP2K1/PIK3CA/AKT1/IRS1/AKT2/EGFR/GRB2/PPP2CA/SRC/ESR1/FOXO3/FOXO4/CREB1/SMAD2/STAT5A",22
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","5/87","11/2914",8.48401296811266e-06,0.000102623926095055,5.70180628626195e-05,"SMAD4/STAT3/KLF4/SMAD2/SOX2",5
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","5/87","11/2914",8.48401296811266e-06,0.000102623926095055,5.70180628626195e-05,"FOXO1/AKT1/AKT2/FOXO3/FOXO4",5
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","10/87","62/2914",1.00657608194542e-05,0.00011945968972522,6.63720475086155e-05,"MAPK1/ABL1/PIK3CA/PRKCD/GRB2/PAK1/SRC/SYK/VAV2/VAV3",10
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","6/87","19/2914",1.18343053169947e-05,0.000137847741562772,7.65884866518956e-05,"FOXO1/SMAD3/SMAD4/FOXO3/FOXO4/SMAD2",6
"R-HSA-1643685","R-HSA-1643685","Disease","29/87","443/2914",1.44975697882976e-05,0.00016579947994253,9.21185295639195e-05,"FOXO1/JUN/MAPK1/PRKACA/RELA/SMAD3/SMAD4/STAT3/TRAF3/CTNNB1/HRAS/MAP2K1/PIK3CA/AKT1/IRS1/MAP2K7/AKT2/EGFR/GRB2/PPP2CA/SRC/TICAM1/TBP/ESR1/FOXO3/FOXO4/CREB1/SMAD2/STAT5A",29
"R-HSA-167044","R-HSA-167044","Signalling to RAS","6/87","20/2914",1.65037112575209e-05,0.000185372042517511,0.000102993085291296,"MAPK14/HRAS/MAPKAPK2/GRB2/MAPK11/SRC",6
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","14/87","130/2914",2.05153804426416e-05,0.000226389022779325,0.000125782203267904,"MAPK1/MAPK14/ABL1/CTNNB1/PLK1/ROCK2/PRKCD/RHOA/GRB2/MAPK11/PAK1/PPP2CA/PRKCA/SRC",14
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","12/87","97/2914",2.09345289407754e-05,0.000227031356961168,0.00012613908545077,"FOXO1/PIK3CA/AKT1/IRS1/AKT2/EGFR/GRB2/SRC/ESR1/FOXO3/FOXO4/CREB1",12
"R-HSA-171007","R-HSA-171007","p38MAPK events","5/87","13/2914",2.25395942725598e-05,0.000236455044910918,0.000131374905715714,"MAPK14/HRAS/MAPKAPK2/MAPK11/SRC",5
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","6/87","21/2914",2.25553301981798e-05,0.000236455044910918,0.000131374905715714,"MAPK1/MAPK14/RPS6KA5/MAPK11/PPP2CA/RPS6KA2",6
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","17/87","187/2914",2.36454098248155e-05,0.000243819061964081,0.000135466368625345,"JUN/MAPK1/MAPK14/MAPK8/RB1/RELA/SIRT1/STAT3/TP53/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/RPS6KA2/FOS/E2F3",17
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","17/87","189/2914",2.72243403364347e-05,0.000276195323735765,0.00015345468576734,"JUN/MAPK1/MAPK14/MAPK8/RB1/RELA/SIRT1/STAT3/TP53/MAP2K7/MAPK10/MAPK9/MAPKAPK2/MAPK11/RPS6KA2/FOS/E2F3",17
"R-HSA-525793","R-HSA-525793","Myogenesis","6/87","22/2914",3.02756940437506e-05,0.000302276373865383,0.000167945370468257,"MAPK14/ABL1/CDON/CTNNB1/SPAG9/MAPK11",6
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","8/87","44/2914",3.36259239148183e-05,0.000330479783475323,0.0001836152424296,"HRAS/PIK3CA/YAP1/EGFR/GRB2/SRC/ESR1/STAT5A",8
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","10/87","72/2914",3.92856576630591e-05,0.000380164287231757,0.000211220054156043,"BCL10/CARD9/PRKACA/RELA/RPS6KA5/HRAS/PRKCD/PAK1/SRC/SYK",10
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","6/87","24/2914",5.20480407205538e-05,0.000474466921930846,0.000263614790529731,"HRAS/PIK3CA/GRB2/SYK/VAV2/VAV3",6
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","6/87","24/2914",5.20480407205538e-05,0.000474466921930846,0.000263614790529731,"HRAS/PIK3CA/GRB2/SYK/VAV2/VAV3",6
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","6/87","24/2914",5.20480407205538e-05,0.000474466921930846,0.000263614790529731,"FOXO1/AKT1/AKT2/FOXO3/FOXO4/CREB1",6
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","6/87","24/2914",5.20480407205538e-05,0.000474466921930846,0.000263614790529731,"MAPK1/RB1/SMAD4/ABL1/YAP1/SRC",6
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","6/87","25/2914",6.68561353493643e-05,0.000600750130496431,0.000333777999037428,"CTNNB1/AKT1/AKT2/PAK1/VAV2/VAV3",6
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","9/87","62/2914",6.89164909158206e-05,0.000610541870226073,0.00033921830962272,"MAPK1/RB1/SMAD4/ABL1/AKT1/AKT2/YAP1/SRC/ESR1",9
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","5/87","16/2914",7.12517919050567e-05,0.000613936672716173,0.000341104468817286,"MAPK1/MAPK14/PRKCD/MAPK11/PRKCA",5
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","5/87","16/2914",7.12517919050567e-05,0.000613936672716173,0.000341104468817286,"HRAS/PIK3CA/IRS1/GRB2/SRC",5
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","16/87","191/2914",0.00011652248579303,0.000990441129240755,0.000550291113560256,"CSNK2A1/CSNK2B/MAPK1/PRKACA/RB1/TP53/ABL1/PLK1/AKT1/AKT2/PPP2CA/PRKCA/SRC/MAX/E2F3/FOXM1",16
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","8/87","53/2914",0.000134971522813046,0.00110915065706699,0.000616246369586213,"SMAD3/SMAD4/TP53/CTNNB1/YAP1/SRC/FOXO3/TEAD4",8
"R-HSA-9013973","R-HSA-9013973","TICAM1-dependent activation of IRF3/IRF7","4/87","10/2914",0.000135778379322986,0.00110915065706699,0.000616246369586213,"IKBKE/TBK1/TRAF3/TICAM1",4
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","4/87","10/2914",0.000135778379322986,0.00110915065706699,0.000616246369586213,"FOXO1/SIRT1/FOXO3/FOXO4",4
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","6/87","29/2914",0.000162878985108239,0.00130138701035598,0.000723053279956801,"STAT3/HRAS/PIK3CA/GRB2/SRC/STAT5A",6
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","7/87","41/2914",0.00016344924295409,0.00130138701035598,0.000723053279956801,"STAT3/HRAS/PIK3CA/GRB2/PRKCA/SRC/STAT5A",7
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","5/87","19/2914",0.000176687112607521,0.00137205177568063,0.000762314767845316,"PRKACA/RELA/RPS6KA5/HRAS/PAK1",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","5/87","19/2914",0.000176687112607521,0.00137205177568063,0.000762314767845316,"MAPK1/RB1/ABL1/YAP1/SRC",5
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","7/87","43/2914",0.000223177808326265,0.00171193709069781,0.000951155742802566,"MAPK1/ABL1/GRB2/PAK1/SYK/VAV2/VAV3",7
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","5/87","20/2914",0.000230081579724187,0.00172287278150612,0.000957231634942734,"MAPK1/RPS6KA4/RPS6KA5/RPS6KA2/SRC",5
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","5/87","20/2914",0.000230081579724187,0.00172287278150612,0.000957231634942734,"MAPK8/RIPK2/MAP2K7/MAPK10/MAPK9",5
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","6/87","31/2914",0.000240618824870402,0.00175987489352887,0.000977790083928684,"PIK3CA/AKT1/AKT2/GRB2/PAK1/SRC",6
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","6/87","31/2914",0.000240618824870402,0.00175987489352887,0.000977790083928684,"MAPK14/PRKCD/AKT1/MAPKAPK2/MAPK11/PRKCA",6
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","6/87","32/2914",0.000289119368120682,0.00207378702417239,0.00115220030461925,"MAPK1/RPS6KA5/HRAS/GRB2/SRC/CREB1",6
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","8/87","59/2914",0.000291670215985677,0.00207378702417239,0.00115220030461925,"CSNK2A1/CSNK2B/JUN/MAPK1/TP53/AKT1/AKT2/EGR1",8
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","17/87","228/2914",0.000293429324564933,0.00207378702417239,0.00115220030461925,"MAPK1/MAPK14/ABL1/CTNNB1/PLK1/ROCK2/PRKCD/RHOA/ARHGAP1/GRB2/MAPK11/PAK1/PPP2CA/PRKCA/SRC/VAV2/VAV3",17
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","4/87","12/2914",0.000305675422001835,0.00213633156043505,0.0011869501766621,"STAT3/PIK3CA/GRB2/STAT5A",4
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","5/87","22/2914",0.00037277407348263,0.00257664716725906,0.00143159042679275,"HRAS/PRKCD/EGFR/GRB2/PRKCA",5
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","13/87","153/2914",0.000479881653321099,0.00328092999933664,0.00182289140620829,"MAPK1/MAPK14/GNAQ/PIK3CA/PRKCD/RHOA/AKT1/GRB2/PRKCA/SRC/SYK/VAV2/VAV3",13
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","7/87","49/2914",0.000514367176674311,0.00344188249072491,0.00191231693903551,"MAPK1/MAPK8/STAT3/TP53/AKT1/AKT2/CASP3",7
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","7/87","49/2914",0.000514367176674311,0.00344188249072491,0.00191231693903551,"JUN/TBP/ESR1/FOS/USF1/FOXA1/POU2F1",7
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","10/87","99/2914",0.000588563301371384,0.00375127165102778,0.0020842141881704,"MAPK1/PIK3CA/AKT1/IRS1/AKT2/EGFR/GRB2/PPP2CA/SRC/ESR1",10
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","4/87","14/2914",0.000590422724088634,0.00375127165102778,0.0020842141881704,"MAPK1/GRB2/PPP2CA/SRC",4
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","4/87","14/2914",0.000590422724088634,0.00375127165102778,0.0020842141881704,"HRAS/PIK3CA/EGFR/GRB2",4
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","4/87","14/2914",0.000590422724088634,0.00375127165102778,0.0020842141881704,"HRAS/PIK3CA/EGFR/GRB2",4
"R-HSA-936964","R-HSA-936964","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon","4/87","14/2914",0.000590422724088634,0.00375127165102778,0.0020842141881704,"IKBKE/TBK1/TRAF3/TICAM1",4
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","6/87","37/2914",0.000657871517834897,0.0041380118471815,0.00229908783074932,"MAPK1/HRAS/PIK3CA/GRB2/PPP2CA/SRC",6
"R-HSA-109581","R-HSA-109581","Apoptosis","10/87","101/2914",0.000691062155533348,0.00430374352307402,0.00239116868824462,"MAPK1/MAPK8/STAT3/TP53/CTNNB1/PRKCD/AKT1/AKT2/CASP3/TICAM1",10
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","6/87","38/2914",0.0007627190784508,0.00470343431711327,0.00261323770944959,"MAPK1/HRAS/PIK3CA/GRB2/PPP2CA/SRC",6
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","4/87","15/2914",0.000786882263626578,0.00480532955166134,0.00266985090980096,"SMAD3/SMAD4/FOXO3/SMAD2",4
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","10/87","103/2914",0.000807923064212412,0.00488638084028468,0.00271488317124009,"MAPK1/MAPK8/STAT3/TP53/CTNNB1/PRKCD/AKT1/AKT2/CASP3/TICAM1",10
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","7/87","53/2914",0.000837745052785176,0.00501849179239882,0.00278828428596169,"PIK3CA/AKT1/AKT2/GRB2/PAK1/PPP2CA/SRC",7
"R-HSA-111996","R-HSA-111996","Ca-dependent events","5/87","26/2914",0.000847349949049941,0.00502814262219258,0.00279364630669891,"MAPK1/PRKACA/PRKCD/PRKCA/CREB1",5
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","5/87","27/2914",0.00101572555453079,0.00591736513203726,0.00328770014866768,"RIPK2/TP53/TRAF3/RHOA/ESR1",5
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","4/87","16/2914",0.00102542575420042,0.00591736513203726,0.00328770014866768,"HRAS/PIK3CA/EGFR/GRB2",4
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","4/87","16/2914",0.00102542575420042,0.00591736513203726,0.00328770014866768,"HRAS/PIK3CA/EGFR/GRB2",4
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","6/87","41/2914",0.00115611693162091,0.00661088681808686,0.00367302221337936,"MAPK1/HRAS/PIK3CA/GRB2/PPP2CA/SRC",6
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","5/87","28/2914",0.00120776974785758,0.00684402857119298,0.00380255624740368,"PIK3CA/RHOA/SYK/VAV2/VAV3",5
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","4/87","17/2914",0.00131060913837639,0.00736047453606029,0.00408949467989627,"PIK3CA/EGFR/GRB2/SRC",4
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","9/87","92/2914",0.00141558129539976,0.00787965163545529,0.00437795053630852,"MAPK1/PIK3CA/AKT1/IRS1/EGFR/GRB2/PPP2CA/SRC/ESR1",9
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","9/87","94/2914",0.00165040620258552,0.00910618860900257,0.00505941698299532,"FOXO1/STAT3/TP53/AKT1/FOS/FOXO3/SOX2/IRF4/POU2F1",9
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","9/87","95/2914",0.00177905248691172,0.00967607500163845,0.00537604702626385,"CSNK2A1/CSNK2B/MAPK14/TP53/AKT1/AKT2/MAPK11/PPP2CA/TBP",9
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","8/87","77/2914",0.00178445898281409,0.00967607500163845,0.00537604702626385,"RB1/ABL1/AKT1/AKT2/PPP2CA/SRC/MAX/E2F3",8
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","6/87","45/2914",0.00190312005616833,0.010231303549828,0.00568453314123154,"JUN/MAPK1/RELA/STAT3/RPS6KA2/FOS",6
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","5/87","31/2914",0.0019458269491455,0.010372247042479,0.00576284163350854,"STAT3/HRAS/PIK3CA/GRB2/STAT5A",5
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","4/87","19/2914",0.00203906039336355,0.0106880748952139,0.00593831623330437,"AKT1/AKT2/PPP2CA/SRC",4
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","4/87","19/2914",0.00203906039336355,0.0106880748952139,0.00593831623330437,"HRAS/PRKCD/PRKCA/SRC",4
"R-HSA-8853659","R-HSA-8853659","RET signaling","5/87","32/2914",0.00225262464933528,0.0117099248300156,0.00650605814336071,"PRKACA/PIK3CA/GRB2/PRKCA/SRC",5
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","16/87","249/2914",0.00230096641991646,0.0118631793289135,0.00659120665584352,"CSNK2A1/CSNK2B/MAPK1/PRKACA/RB1/TP53/ABL1/PLK1/AKT1/AKT2/PPP2CA/PRKCA/SRC/MAX/E2F3/FOXM1",16
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","6/87","47/2914",0.00239175204695384,0.0121575426574889,0.0067547555221928,"MAPK1/PRKACA/HRAS/RPS6KA2/SRC/CREB1",6
"R-HSA-109582","R-HSA-109582","Hemostasis","18/87","298/2914",0.00239671747142865,0.0121575426574889,0.0067547555221928,"MAPK1/MAPK14/PRKACA/TP53/ABL1/GNAQ/HRAS/PIK3CA/PRKCD/RHOA/AKT1/GRB2/PPP2CA/PRKCA/SRC/SYK/VAV2/VAV3",18
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","5/87","33/2914",0.00259327442053836,0.0129237147382279,0.00718044229452207,"MAPK1/RB1/PLK1/PPP2CA/PRKCA",5
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","3/87","10/2914",0.00265049157588458,0.0129237147382279,0.00718044229452207,"TP53/AKT1/AKT2",3
"R-HSA-74749","R-HSA-74749","Signal attenuation","3/87","10/2914",0.00265049157588458,0.0129237147382279,0.00718044229452207,"MAPK1/IRS1/GRB2",3
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","3/87","10/2914",0.00265049157588458,0.0129237147382279,0.00718044229452207,"HRAS/PIK3CA/GRB2",3
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","3/87","10/2914",0.00265049157588458,0.0129237147382279,0.00718044229452207,"CSNK2A1/CSNK2B/SRC",3
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","6/87","49/2914",0.00296953452244201,0.0137108253431389,0.00761776255363084,"STAT3/HRAS/PIK3CA/GRB2/SRC/STAT5A",6
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","6/87","49/2914",0.00296953452244201,0.0137108253431389,0.00761776255363084,"MAPK1/PRKACA/HRAS/RPS6KA2/SRC/CREB1",6
"R-HSA-112040","R-HSA-112040","G-protein mediated events","5/87","34/2914",0.00296987734118034,0.0137108253431389,0.00761776255363084,"MAPK1/PRKACA/PRKCD/PRKCA/CREB1",5
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","5/87","34/2914",0.00296987734118034,0.0137108253431389,0.00761776255363084,"MAPK1/PRKACA/PRKCD/PRKCA/CREB1",5
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/87","34/2914",0.00296987734118034,0.0137108253431389,0.00761776255363084,"RELA/TBK1/CTNNB1/PRKDC/TICAM1",5
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","5/87","34/2914",0.00296987734118034,0.0137108253431389,0.00761776255363084,"ROCK2/HRAS/RHOA/PAK1/SRC",5
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","5/87","34/2914",0.00296987734118034,0.0137108253431389,0.00761776255363084,"FOXO1/JUN/PRKACA/PAK1/FOXO3",5
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","4/87","21/2914",0.00300809840596688,0.0137108253431389,0.00761776255363084,"RHOA/AKT1/AKT2/PAK1",4
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","4/87","21/2914",0.00300809840596688,0.0137108253431389,0.00761776255363084,"MAPK14/RIPK2/MAPKAPK2/MAPK11",4
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","6/87","50/2914",0.00329486464574602,0.0149098551235557,0.00828394594765375,"MAPK1/HRAS/PIK3CA/GRB2/PPP2CA/SRC",6
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","5/87","35/2914",0.0033845415662557,0.0152062617512488,0.00844863007516461,"MAPK14/MAPK8/MAPK11/PAK1/SRC",5
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/87","11/2914",0.00356623166037627,0.0154825594265173,0.00860214162765247,"FOXO1/AKT1/AKT2",3
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","3/87","11/2914",0.00356623166037627,0.0154825594265173,0.00860214162765247,"STAT3/IRS1/STAT5A",3
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","3/87","11/2914",0.00356623166037627,0.0154825594265173,0.00860214162765247,"ROCK2/RHOA/PAK1",3
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","3/87","11/2914",0.00356623166037627,0.0154825594265173,0.00860214162765247,"HRAS/PIK3CA/GRB2",3
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","4/87","22/2914",0.00359372603540782,0.0154825594265173,0.00860214162765247,"HRAS/PIK3CA/EGFR/GRB2",4
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","4/87","22/2914",0.00359372603540782,0.0154825594265173,0.00860214162765247,"MAPK1/HRAS/RPS6KA2/CREB1",4
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","7/87","68/2914",0.00366598714074558,0.0156864347723059,0.00871541518601885,"ROCK2/HRAS/RHOA/PAK1/SRC/VAV2/VAV3",7
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","6/87","52/2914",0.00402453571385378,0.0169894829799599,0.00943939143058604,"MAPK1/HRAS/PIK3CA/IRS1/AKT2/GRB2",6
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","6/87","52/2914",0.00402453571385378,0.0169894829799599,0.00943939143058604,"MAPK1/HRAS/PIK3CA/IRS1/AKT2/GRB2",6
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/87","23/2914",0.00425235994827438,0.0178315627164305,0.00990725265141819,"MAPK1/RB1/TP53/E2F3",4
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","6/87","53/2914",0.00443136005356464,0.0184591090972991,0.0102559187018715,"BCL10/CARD9/RELA/PRKCD/SRC/SYK",6
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","3/87","12/2914",0.00465308373983442,0.0192551952128674,0.0106982257730265,"SMAD3/SMAD4/SMAD2",3
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","4/87","24/2914",0.00498804332130401,0.0202418016070982,0.011246386299986,"STAT3/PIK3CA/GRB2/STAT5A",4
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","4/87","24/2914",0.00498804332130401,0.0202418016070982,0.011246386299986,"HRAS/PIK3CA/GRB2/STAT5A",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/87","24/2914",0.00498804332130401,0.0202418016070982,0.011246386299986,"MAPK1/STAT3/IRS1/STAT5A",4
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","6/87","55/2914",0.00533524420714359,0.02151197824547,0.011952099033547,"MAPK1/HRAS/PIK3CA/GRB2/PPP2CA/SRC",6
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","4/87","25/2914",0.00580467732153899,0.022515953304057,0.0125099096258839,"PRKACA/PRKCD/PRKCA/CREB1",4
"R-HSA-111997","R-HSA-111997","CaM pathway","4/87","25/2914",0.00580467732153899,0.022515953304057,0.0125099096258839,"PRKACA/PRKCD/PRKCA/CREB1",4
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","4/87","25/2914",0.00580467732153899,0.022515953304057,0.0125099096258839,"AKT1/GRB2/SRC/SYK",4
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","4/87","25/2914",0.00580467732153899,0.022515953304057,0.0125099096258839,"CSNK2A1/CSNK2B/AKT1/AKT2",4
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","4/87","25/2914",0.00580467732153899,0.022515953304057,0.0125099096258839,"HRAS/PIK3CA/GRB2/SRC",4
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","4/87","25/2914",0.00580467732153899,0.022515953304057,0.0125099096258839,"AKT1/GRB2/SRC/SYK",4
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","6/87","56/2914",0.00583481778785579,0.022515953304057,0.0125099096258839,"CSNK2A1/CSNK2B/MAPK14/TP53/MAPK11/TBP",6
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","3/87","13/2914",0.00591955479148696,0.0225660603869412,0.0125377492234365,"HRAS/EGFR/GRB2",3
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","3/87","13/2914",0.00591955479148696,0.0225660603869412,0.0125377492234365,"FOXO1/FOXO3/FOXO4",3
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","13/87","202/2914",0.00607036120466845,0.022847414980965,0.0126940704103094,"FOXO1/JUN/MAPK1/PRKACA/HRAS/MAP2K1/IRS1/EGFR/GRB2/PAK1/PPP2CA/SRC/FOXO3",13
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","5/87","40/2914",0.00610233023338968,0.022847414980965,0.0126940704103094,"RB1/ABL1/PPP2CA/SRC/E2F3",5
"R-HSA-69236","R-HSA-69236","G1 Phase","5/87","40/2914",0.00610233023338968,0.022847414980965,0.0126940704103094,"RB1/ABL1/PPP2CA/SRC/E2F3",5
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","5/87","41/2914",0.00678930430307979,0.0252218289051394,0.0140132996343508,"STAT3/PIK3CA/GRB2/SYK/STAT5A",5
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","7/87","76/2914",0.00681671051490255,0.0252218289051394,0.0140132996343508,"MAPK8/RELA/RIPK2/RHOA/CASP3/VAV2/VAV3",7
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","7/87","77/2914",0.0073199356681114,0.0265005048381709,0.0147237345933775,"MAPK1/PRKACA/HRAS/PRKCA/RPS6KA2/SRC/CREB1",7
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","3/87","14/2914",0.00737295444623196,0.0265005048381709,0.0147237345933775,"HRAS/EGFR/GRB2",3
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","3/87","14/2914",0.00737295444623196,0.0265005048381709,0.0147237345933775,"TP53/AKT1/AKT2",3
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","3/87","14/2914",0.00737295444623196,0.0265005048381709,0.0147237345933775,"STAT3/GRB2/STAT5A",3
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","3/87","14/2914",0.00737295444623196,0.0265005048381709,0.0147237345933775,"IKBKE/TBK1/TRAF3",3
"R-HSA-111885","R-HSA-111885","Opioid Signalling","6/87","59/2914",0.0075391399384279,0.0269438580754043,0.0149700625571654,"MAPK1/PRKACA/PRKCD/PPP2CA/PRKCA/CREB1",6
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","4/87","27/2914",0.00769562418265666,0.0270421654239723,0.015024682320741,"YAP1/SRC/ESR1/STAT5A",4
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","4/87","27/2914",0.00769562418265666,0.0270421654239723,0.015024682320741,"MAPK1/GRB2/PPP2CA/SRC",4
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/87","27/2914",0.00769562418265666,0.0270421654239723,0.015024682320741,"STAT3/RARA/CREB1/FLI1",4
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","4/87","28/2914",0.00877693325512317,0.0306705056526249,0.0170405955596543,"MAPK1/GRB2/PPP2CA/SRC",4
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","3/87","15/2914",0.00901947249188329,0.0308328706380141,0.0171308058770323,"GRB2/PRKCA/SRC",3
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","3/87","15/2914",0.00901947249188329,0.0308328706380141,0.0171308058770323,"PIK3CA/GRB2/SYK",3
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","3/87","15/2914",0.00901947249188329,0.0308328706380141,0.0171308058770323,"CTNNB1/GRB2/SRC",3
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","3/87","15/2914",0.00901947249188329,0.0308328706380141,0.0171308058770323,"SMAD3/STAT3/TBK1",3
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","5/87","44/2914",0.00917329504877619,0.0311892031658391,0.0173287849570054,"HRAS/PIK3CA/EGFR/GRB2/SRC",5
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","4/87","29/2914",0.00995316972419401,0.0329502302974633,0.0183072152267724,"MAPK8/TP53/AKT1/AKT2",4
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","4/87","29/2914",0.00995316972419401,0.0329502302974633,0.0183072152267724,"GRB2/SYK/VAV2/VAV3",4
"R-HSA-5673000","R-HSA-5673000","RAF activation","4/87","29/2914",0.00995316972419401,0.0329502302974633,0.0183072152267724,"HRAS/MAP2K1/PPP2CA/SRC",4
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","4/87","29/2914",0.00995316972419401,0.0329502302974633,0.0183072152267724,"TP53/AKT1/AKT2/PPP2CA",4
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","4/87","29/2914",0.00995316972419401,0.0329502302974633,0.0183072152267724,"TP53/AKT1/AKT2/PPP2CA",4
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","5/87","45/2914",0.0100820669228522,0.0330292713253855,0.0183511305832617,"STAT3/HRAS/PIK3CA/GRB2/STAT5A",5
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","5/87","45/2914",0.0100820669228522,0.0330292713253855,0.0183511305832617,"PRKACA/PIK3CA/GRB2/SYK/STAT5A",5
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","7/87","82/2914",0.0102601419883627,0.0334384938377211,0.0185784954466127,"MAPK8/RELA/RIPK2/SMAD3/STAT3/TBK1/MAP2K1",7
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","9/87","124/2914",0.0105761742705267,0.0342907918358828,0.0190520339545027,"RIPK2/SMAD3/SMAD4/TP53/TRAF3/RHOA/ESR1/FOXO4/SMAD2",9
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","3/87","16/2914",0.0108642525082717,0.0345132062005195,0.0191756078295916,"HRAS/EGFR/GRB2",3
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","3/87","16/2914",0.0108642525082717,0.0345132062005195,0.0191756078295916,"PIK3CA/EGFR/GRB2",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/87","16/2914",0.0108642525082717,0.0345132062005195,0.0191756078295916,"RHOA/AKT1/AKT2",3
"R-HSA-5205647","R-HSA-5205647","Mitophagy","3/87","16/2914",0.0108642525082717,0.0345132062005195,0.0191756078295916,"CSNK2A1/CSNK2B/SRC",3
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","5/87","46/2914",0.0110509914617604,0.0347882903656052,0.0193284451533444,"HRAS/PIK3CA/IRS1/AKT2/GRB2",5
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","6/87","64/2914",0.0111395004579156,0.0347882903656052,0.0193284451533444,"PRKACA/ABL1/RHOA/PAK1/PRKCA/SRC",6
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","4/87","30/2914",0.0112273814693448,0.0347882903656052,0.0193284451533444,"PRKACA/PRKCD/PRKCA/CREB1",4
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","4/87","30/2914",0.0112273814693448,0.0347882903656052,0.0193284451533444,"CSNK2A1/CSNK2B/STAT3/TP53",4
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","4/87","30/2914",0.0112273814693448,0.0347882903656052,0.0193284451533444,"MAPK1/GRB2/PPP2CA/SRC",4
"R-HSA-68886","R-HSA-68886","M Phase","8/87","105/2914",0.0119727869570818,0.0368907073967122,0.0204965523482695,"CSNK2A1/CSNK2B/MAPK1/PRKACA/RB1/PLK1/PPP2CA/PRKCA",8
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","5/87","47/2914",0.0120818532968564,0.0368907073967122,0.0204965523482695,"STAT3/HRAS/RHOA/AKT1/EGFR",5
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","5/87","47/2914",0.0120818532968564,0.0368907073967122,0.0204965523482695,"STAT3/HRAS/RHOA/AKT1/EGFR",5
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","4/87","31/2914",0.0126024265834484,0.0381102226970626,0.0211741175389922,"CTNNB1/AKT1/AKT2/SOX2",4
"R-HSA-391251","R-HSA-391251","Protein folding","4/87","31/2914",0.0126024265834484,0.0381102226970626,0.0211741175389922,"CSNK2A1/CSNK2B/STAT3/TP53",4
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","3/87","17/2914",0.0129114618018206,0.0384896183570862,0.0213849105423021,"PIK3CA/PRKCD/SYK",3
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","3/87","17/2914",0.0129114618018206,0.0384896183570862,0.0213849105423021,"HRAS/PIK3CA/GRB2",3
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","3/87","17/2914",0.0129114618018206,0.0384896183570862,0.0213849105423021,"MAPK14/GNAQ/SRC",3
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","5/87","48/2914",0.0131763825422787,0.0390940783919495,0.0217207497717801,"CARD9/MAPK14/RELA/RIPK2/MAPK11",5
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","4/87","32/2914",0.0140809697168931,0.0411950230322128,0.0228880389033464,"MAPK1/GRB2/PPP2CA/SRC",4
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","4/87","32/2914",0.0140809697168931,0.0411950230322128,0.0228880389033464,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/87","32/2914",0.0140809697168931,0.0411950230322128,0.0228880389033464,"JUN/MAPK1/TP53/EGR1",4
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/87","68/2914",0.0147903318267604,0.0429943228692648,0.0238877335663893,"PRKACA/TP53/PLK1/PPP2CA/E2F3/FOXM1",6
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","7/87","88/2914",0.0148326996226239,0.0429943228692648,0.0238877335663893,"MAPK1/PRKACA/HRAS/PRKCA/RPS6KA2/SRC/CREB1",7
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/87","18/2914",0.0151643578005965,0.043754041543923,0.0243098348131243,"PLK1/PPP2CA/FOXM1",3
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","5/87","50/2914",0.0155630724120748,0.0445863644829888,0.0247722751373982,"HRAS/PIK3CA/IRS1/AKT2/GRB2",5
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","4/87","33/2914",0.015665479412942,0.0445863644829888,0.0247722751373982,"CARD9/MAPK14/RIPK2/MAPK11",4
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","4/87","33/2914",0.015665479412942,0.0445863644829888,0.0247722751373982,"AKT1/GRB2/SRC/SYK",4
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","5/87","51/2914",0.0168583934136357,0.0475512531711965,0.0264195733458911,"HRAS/PIK3CA/IRS1/AKT2/GRB2",5
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","5/87","51/2914",0.0168583934136357,0.0475512531711965,0.0264195733458911,"HRAS/PIK3CA/IRS1/AKT2/GRB2",5
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","4/87","34/2914",0.0173582263558436,0.0485258861236694,0.0269610814041641,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","4/87","34/2914",0.0173582263558436,0.0485258861236694,0.0269610814041641,"MAPK1/HRAS/MAP2K1/PPP2CA",4
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","3/87","19/2914",0.0176253510644527,0.0490546275200918,0.0272548512035319,"RELA/TBK1/TICAM1",3
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","6/87","72/2914",0.0192046345193393,0.0532146040205482,0.0295661426404853,"PIK3CA/IRS1/EGFR/GRB2/SRC/ESR1",6
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/87","20/2914",0.020296065058749,0.0552650429521781,0.0307053706972189,"SMAD3/SMAD4/SMAD2",3
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","3/87","20/2914",0.020296065058749,0.0552650429521781,0.0307053706972189,"RELA/TRAF3/TICAM1",3
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","3/87","20/2914",0.020296065058749,0.0552650429521781,0.0307053706972189,"RELA/TRAF3/TICAM1",3
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","3/87","20/2914",0.020296065058749,0.0552650429521781,0.0307053706972189,"PIK3CA/GRB2/SYK",3
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","11/87","188/2914",0.0223608290087393,0.0606248338211079,0.0336832814469213,"MAPK1/HRAS/MAP2K1/PIK3CA/IRS1/AKT2/EGFR/GRB2/PPP2CA/SRC/STAT5A",11
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","3/87","21/2914",0.0231773928342127,0.0620365110328502,0.0344676121879446,"CTNNB1/PRKCD/CASP3",3
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/87","21/2914",0.0231773928342127,0.0620365110328502,0.0344676121879446,"PIK3CA/AKT1/AKT2",3
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","3/87","21/2914",0.0231773928342127,0.0620365110328502,0.0344676121879446,"ROCK2/RHOA/SRC",3
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","10/87","165/2914",0.0233816780245982,0.0623181164299673,0.0346240727215281,"MAPK1/GNAQ/HRAS/PIK3CA/PRKCD/EGFR/GRB2/PRKCA/RPS6KA2/CREB1",10
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","5/87","56/2914",0.0244119786400116,0.0647895973188495,0.0359972325493398,"CSNK2A1/CSNK2B/PRKACA/PLK1/PPP2CA",5
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","3/87","22/2914",0.0262695507498135,0.068848114256803,0.0382521528462197,"STAT3/IRS1/STAT5A",3
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","3/87","22/2914",0.0262695507498135,0.068848114256803,0.0382521528462197,"HRAS/PIK3CA/GRB2",3
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","3/87","22/2914",0.0262695507498135,0.068848114256803,0.0382521528462197,"HRAS/PIK3CA/GRB2",3
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","4/87","39/2914",0.0275110908196599,0.0715372264932184,0.0397462290950523,"RB1/AKT1/AKT2/MAX",4
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","11/87","194/2914",0.0275230664727486,0.0715372264932184,0.0397462290950523,"CSNK2A1/CSNK2B/JUN/MAPK14/TP53/AKT1/AKT2/MAPK11/PPP2CA/TBP/FOS",11
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","20/87","436/2914",0.0286747646320341,0.0742239792327139,0.0412389944025789,"MAPK1/PRKACA/ROCK2/GNAQ/HRAS/PIK3CA/PRKCD/RHOA/AKT1/AKT2/EGFR/GRB2/PAK1/PPP2CA/PRKCA/RPS6KA2/SRC/VAV2/VAV3/CREB1",20
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/87","23/2914",0.0295721293700444,0.0759219158112567,0.0421823714322437,"JUN/TP53/E2F3",3
"R-HSA-392518","R-HSA-392518","Signal amplification","3/87","23/2914",0.0295721293700444,0.0759219158112567,0.0421823714322437,"MAPK14/GNAQ/SRC",3
"R-HSA-202403","R-HSA-202403","TCR signaling","5/87","59/2914",0.0298501620875871,0.0761162373094282,0.0422903368533682,"BCL10/RELA/RIPK2/PIK3CA/PAK1",5
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","4/87","40/2914",0.0298898419959122,0.0761162373094282,0.0422903368533682,"RB1/AKT1/AKT2/MAX",4
"R-HSA-69206","R-HSA-69206","G1/S Transition","5/87","60/2914",0.0318201816519755,0.0807052187866636,0.0448399843313067,"RB1/AKT1/AKT2/PPP2CA/MAX",5
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/87","24/2914",0.0330841416627216,0.0829080681508043,0.0460638919355151,"FOXO1/AKT1/AKT2",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/87","24/2914",0.0330841416627216,0.0829080681508043,0.0460638919355151,"SMAD3/SMAD4/SMAD2",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/87","24/2914",0.0330841416627216,0.0829080681508043,0.0460638919355151,"AKT1/AKT2/EGFR",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","7/87","104/2914",0.0338390860485427,0.0833829973473598,0.0463277635667701,"JUN/SMAD3/TP53/AKT1/EGFR/CREB1/E2F3",7
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/87","10/2914",0.0339364822272243,0.0833829973473598,0.0463277635667701,"RB1/PPP2CA",2
"R-HSA-2029481","R-HSA-2029481","FCGR activation","2/87","10/2914",0.0339364822272243,0.0833829973473598,0.0463277635667701,"SRC/SYK",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/87","10/2914",0.0339364822272243,0.0833829973473598,0.0463277635667701,"IKBKE/RELA",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/87","10/2914",0.0339364822272243,0.0833829973473598,0.0463277635667701,"STAT3/STAT5A",2
"R-HSA-109704","R-HSA-109704","PI3K Cascade","4/87","42/2914",0.0350038688568372,0.0843579828005771,0.0468694674751763,"PIK3CA/IRS1/AKT2/GRB2",4
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","4/87","42/2914",0.0350038688568372,0.0843579828005771,0.0468694674751763,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","4/87","42/2914",0.0350038688568372,0.0843579828005771,0.0468694674751763,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","4/87","42/2914",0.0350038688568372,0.0843579828005771,0.0468694674751763,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","4/87","42/2914",0.0350038688568372,0.0843579828005771,0.0468694674751763,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-112316","R-HSA-112316","Neuronal System","7/87","105/2914",0.0354009645550756,0.0849893385692463,0.0472202500292692,"MAPK1/PRKACA/HRAS/PRKCA/RPS6KA2/SRC/CREB1",7
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","5/87","62/2914",0.0360011705371739,0.0861016588132411,0.0478382574278237,"STAT3/HRAS/PIK3CA/GRB2/SRC",5
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","3/87","25/2914",0.0368040686183374,0.0870291697779481,0.0483535844134864,"MAPK1/GNAQ/SRC",3
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","3/87","25/2914",0.0368040686183374,0.0870291697779481,0.0483535844134864,"HRAS/PIK3CA/GRB2",3
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/87","25/2914",0.0368040686183374,0.0870291697779481,0.0483535844134864,"MAPK1/ABL1/GRB2",3
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","7/87","106/2914",0.0370103243569192,0.087189116181656,0.0484424509619443,"MAPK8/RELA/RIPK2/RHOA/CASP3/VAV2/VAV3",7
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","4/87","43/2914",0.0377403846281636,0.0885772460116228,0.0492136987295771,"BCL10/RELA/RIPK2/PIK3CA",4
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","5/87","63/2914",0.0382135351183005,0.0893543256111933,0.0496454457416387,"BCL10/RELA/HRAS/GRB2/SYK",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/87","108/2914",0.040373378391428,0.0914968164788287,0.0508358180419565,"CSNK2A1/CSNK2B/CTNNB1/AKT1/AKT2/PPP2CA/SOX2",7
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"RB1/PPP2CA",2
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"AKT1/AKT2",2
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"TBK1/PRKDC",2
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"ROCK2/RHOA",2
"R-HSA-5210891","R-HSA-5210891","Uptake and function of anthrax toxins","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"MAP2K1/MAP2K7",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"EGFR/ESR1",2
"R-HSA-9028731","R-HSA-9028731","Activated NTRK2 signals through FRS2 and FRS3","2/87","11/2914",0.0406854267976351,0.0914968164788287,0.0508358180419565,"HRAS/GRB2",2
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","3/87","26/2914",0.0407299024071098,0.0914968164788287,0.0508358180419565,"HRAS/PIK3CA/GRB2",3
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","3/87","26/2914",0.0407299024071098,0.0914968164788287,0.0508358180419565,"CTNNB1/PRKCD/CASP3",3
"R-HSA-936440","R-HSA-936440","Negative regulators of DDX58/IFIH1 signaling","3/87","26/2914",0.0407299024071098,0.0914968164788287,0.0508358180419565,"IKBKE/TBK1/TRAF3",3
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","6/87","86/2914",0.0415435700749214,0.0929925465378134,0.0516668487165158,"CSNK2A1/CSNK2B/ABL1/YAP1/SRC/ESR1",6
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","7/87","109/2914",0.0421279583927489,0.0939662618051031,0.0522078469070274,"MAPK14/PRKCD/AKT1/MAPKAPK2/MAPK11/PPP2CA/PRKCA",7
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","5/87","66/2914",0.0453448205985048,0.100429197734012,0.0557986673043128,"IKBKE/RELA/TBK1/TRAF3/MAP3K1",5
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/87","66/2914",0.0453448205985048,0.100429197734012,0.0557986673043128,"PRKACA/TP53/PLK1/PPP2CA/FOXM1",5
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","4/87","46/2914",0.0466716148720664,0.102812294240218,0.0571227205886574,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"MAPK1/CASP3",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"CSNK2A1/CSNK2B",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"MAPK1/MAP2K1",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"MAPK1/PPP2CA",2
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"YAP1/TEAD4",2
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"GRB2/PAK1",2
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"PRKACA/CREB1",2
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","2/87","12/2914",0.0478918954091951,0.102812294240218,0.0571227205886574,"SYK/STAT5A",2
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/87","28/2914",0.0491890576567716,0.10452674752064,0.058075274331608,"SMAD3/SMAD4/SMAD2",3
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","3/87","28/2914",0.0491890576567716,0.10452674752064,0.058075274331608,"VDR/ESR1/RARA",3
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","3/87","28/2914",0.0491890576567716,0.10452674752064,0.058075274331608,"HRAS/PIK3CA/GRB2",3
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","4/87","47/2914",0.0498892671116208,0.105657740785217,0.0587036564985225,"PLK1/RHOA/PPP2CA/SRC",4
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","14/87","296/2914",0.0529589941016923,0.111782574798538,0.0621066267812146,"BCL10/PRKACA/RELA/RIPK2/HRAS/PIK3CA/AKT1/AKT2/CBLB/GRB2/PAK1/PPP2CA/SRC/SYK",14
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/87","29/2914",0.0537162754951459,0.113001796944638,0.062784029094837,"JUN/TP53/E2F3",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"PRKACA/CREB1",2
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"MAPK1/MAP2K1",2
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"RELA/RIPK2",2
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"AKT1/AKT2",2
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"GRB2/SRC",2
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"TBP/POU2F1",2
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","2/87","13/2914",0.0555232300669603,0.114131084026529,0.0634114633031676,"AKT1/AKT2",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","4/87","49/2914",0.0566837398890948,0.116137043616419,0.064525978546818,"MAPK1/HRAS/MAP2K1/SRC",4
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","3/87","30/2914",0.0584372637202349,0.118954818381967,0.066091539959523,"CSNK2A1/CSNK2B/PIK3CA",3
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","3/87","30/2914",0.0584372637202349,0.118954818381967,0.066091539959523,"HRAS/PIK3CA/GRB2",3
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"HRAS/GRB2",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"CTNNB1/PPP2CA",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"CTNNB1/PPP2CA",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"CTNNB1/PPP2CA",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"CTNNB1/PPP2CA",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"CTNNB1/PPP2CA",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"CTNNB1/PPP2CA",2
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"RHOA/EGFR",2
"R-HSA-8849471","R-HSA-8849471","PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"HRAS/RHOA",2
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","2/87","14/2914",0.0635482760037484,0.125303653938425,0.0696189659569195,"HRAS/GRB2",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","9/87","172/2914",0.0681323672070726,0.133701066021367,0.0742845852549477,"CSNK2A1/CSNK2B/CTNNB1/RHOA/AKT1/AKT2/PPP2CA/PRKCA/SOX2",9
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/87","32/2914",0.0684447428599051,0.133701066021367,0.0742845852549477,"MAPK1/SIRT1/MAPKAPK2",3
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","3/87","32/2914",0.0684447428599051,0.133701066021367,0.0742845852549477,"HRAS/PIK3CA/GRB2",3
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","2/87","15/2914",0.0719373226978814,0.137952975539535,0.0766469548642382,"AKT1/AKT2",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","2/87","15/2914",0.0719373226978814,0.137952975539535,0.0766469548642382,"YAP1/CASP3",2
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","2/87","15/2914",0.0719373226978814,0.137952975539535,0.0766469548642382,"ROCK2/RHOA",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/87","15/2914",0.0719373226978814,0.137952975539535,0.0766469548642382,"MAPK14/PPP2CA",2
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","2/87","15/2914",0.0719373226978814,0.137952975539535,0.0766469548642382,"JUN/FOXO3",2
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","2/87","15/2914",0.0719373226978814,0.137952975539535,0.0766469548642382,"JUN/FOXO3",2
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","20/87","486/2914",0.0764768129844627,0.146212508714976,0.0812359683597556,"MAPK1/PRKACA/ROCK2/GNAQ/HRAS/PIK3CA/PRKCD/RHOA/AKT1/AKT2/EGFR/GRB2/PAK1/PPP2CA/PRKCA/RPS6KA2/SRC/VAV2/VAV3/CREB1",20
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","3/87","34/2914",0.0791772927060942,0.150460776773817,0.0835963147668096,"MAPK8/TP53/ABL1",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/87","34/2914",0.0791772927060942,0.150460776773817,0.0835963147668096,"JUN/TP53/FOS",3
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","4/87","55/2914",0.0798876655220949,0.15055319753626,0.0836476639311158,"PRKACA/GNAQ/PPP2CA/PRKCA",4
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/87","16/2914",0.0806620470106829,0.15055319753626,0.0836476639311158,"MAPK1/CASP3",2
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","2/87","16/2914",0.0806620470106829,0.15055319753626,0.0836476639311158,"RELA/TICAM1",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/87","16/2914",0.0806620470106829,0.15055319753626,0.0836476639311158,"CTNNB1/PPP2CA",2
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","2/87","16/2914",0.0806620470106829,0.15055319753626,0.0836476639311158,"PAK1/SRC",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/87","16/2914",0.0806620470106829,0.15055319753626,0.0836476639311158,"TP53/PLK1",2
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","3/87","35/2914",0.0848037936668787,0.157349811847984,0.0874238767191545,"TP53/AKT1/AKT2",3
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","3/87","35/2914",0.0848037936668787,0.157349811847984,0.0874238767191545,"MAPK8/TP53/ABL1",3
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","4/87","57/2914",0.0885329907600654,0.162856939248241,0.0904836479464746,"CTNNB1/PIK3CA/GRB2/SRC",4
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","5/87","80/2914",0.0885486060777397,0.162856939248241,0.0904836479464746,"MAPK14/PRKACA/PLK1/MAPK11/CREB1",5
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","5/87","80/2914",0.0885486060777397,0.162856939248241,0.0904836479464746,"SMAD3/SMAD4/TP53/FOXO4/SMAD2",5
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","2/87","17/2914",0.0896954583718644,0.164485257480766,0.0913883448809544,"SIRT1/TBP",2
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/87","36/2914",0.090597182117085,0.165655894045484,0.0920387529463654,"SMAD3/SMAD4/SMAD2",3
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","6/87","107/2914",0.0977787111918487,0.178269012578762,0.0990466273552822,"IKBKE/RELA/TP53/VDR/ESR1/RARA",6
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","2/87","18/2914",0.0990118459432729,0.178961066374479,0.0994311338571282,"HRAS/GRB2",2
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","2/87","18/2914",0.0990118459432729,0.178961066374479,0.0994311338571282,"PIK3CA/GRB2",2
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","2/87","18/2914",0.0990118459432729,0.178961066374479,0.0994311338571282,"CSNK2A1/CSNK2B",2
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","3/87","38/2914",0.102663943915542,0.18450177349393,0.102509562044992,"MAPK14/MAPK11/CREB1",3
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","3/87","38/2914",0.102663943915542,0.18450177349393,0.102509562044992,"ROCK2/RHOA/PAK1",3
"R-HSA-2990846","R-HSA-2990846","SUMOylation","6/87","109/2914",0.104593992779943,0.187434818970326,0.104139168099989,"IKBKE/RELA/TP53/VDR/ESR1/RARA",6
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","4/87","61/2914",0.107116697072664,0.190867995633727,0.106046648063589,"MAPK8/CASP3/VAV2/VAV3",4
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","4/87","61/2914",0.107116697072664,0.190867995633727,0.106046648063589,"ROCK2/RHOA/VAV2/VAV3",4
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","2/87","19/2914",0.108586727693722,0.191319472603225,0.106297489589609,"PLK1/PRKCA",2
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","2/87","19/2914",0.108586727693722,0.191319472603225,0.106297489589609,"HRAS/GRB2",2
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","2/87","19/2914",0.108586727693722,0.191319472603225,0.106297489589609,"PIK3CA/GRB2",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/87","19/2914",0.108586727693722,0.191319472603225,0.106297489589609,"CSNK2A1/CSNK2B",2
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","3/87","39/2914",0.108926681673532,0.191382354113551,0.106332426685129,"BCL10/RELA/HRAS",3
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","4/87","63/2914",0.117025126722096,0.205038453226179,0.113919783233356,"SMAD3/SMAD4/RHOA/SMAD2",4
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","2/87","20/2914",0.11839680131983,0.205155889890285,0.113985031283699,"MAP2K1/MAP2K7",2
"R-HSA-5654706","R-HSA-5654706","FRS-mediated FGFR3 signaling","2/87","20/2914",0.11839680131983,0.205155889890285,0.113985031283699,"HRAS/GRB2",2
"R-HSA-70171","R-HSA-70171","Glycolysis","2/87","20/2914",0.11839680131983,0.205155889890285,0.113985031283699,"PRKACA/PPP2CA",2
"R-HSA-70326","R-HSA-70326","Glucose metabolism","2/87","20/2914",0.11839680131983,0.205155889890285,0.113985031283699,"PRKACA/PPP2CA",2
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","3/87","41/2914",0.121883590658061,0.210617523417364,0.117019526022199,"PRKACA/CREB1/SOX2",3
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","2/87","21/2914",0.128419896949896,0.219155610970177,0.1217633048985,"HRAS/GRB2",2
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","2/87","21/2914",0.128419896949896,0.219155610970177,0.1217633048985,"PIK3CA/GRB2",2
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","2/87","21/2914",0.128419896949896,0.219155610970177,0.1217633048985,"HRAS/GRB2",2
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","2/87","21/2914",0.128419896949896,0.219155610970177,0.1217633048985,"RELA/MAP3K1",2
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","3/87","42/2914",0.128566646181232,0.219155610970177,0.1217633048985,"SRC/VAV2/VAV3",3
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","8/87","171/2914",0.135063800412964,0.229608460702039,0.127570929550794,"MAPK1/HRAS/MAP2K1/IRS1/EGFR/GRB2/PPP2CA/SRC",8
"R-HSA-180024","R-HSA-180024","DARPP-32 events","2/87","22/2914",0.138634931569904,0.233158748549384,0.129543476727295,"PRKACA/PPP2CA",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/87","22/2914",0.138634931569904,0.233158748549384,0.129543476727295,"SMAD3/SMAD2",2
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","2/87","22/2914",0.138634931569904,0.233158748549384,0.129543476727295,"BCL10/PRKDC",2
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","2/87","22/2914",0.138634931569904,0.233158748549384,0.129543476727295,"PRKACA/CREB1",2
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","6/87","119/2914",0.142253460219215,0.238606470607696,0.132570242225345,"CSNK2A1/CSNK2B/PRKACA/PIK3CA/MAPKAPK2/VDR",6
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","4/87","69/2914",0.149010553123948,0.245946711671247,0.136648495146606,"HRAS/PIK3CA/GRB2/SRC",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","2/87","23/2914",0.149021865112748,0.245946711671247,0.136648495146606,"MAPK1/MAP2K1",2
"R-HSA-5357769","R-HSA-5357769","Caspase activation via extrinsic apoptotic signalling pathway","2/87","23/2914",0.149021865112748,0.245946711671247,0.136648495146606,"CASP3/TICAM1",2
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","2/87","23/2914",0.149021865112748,0.245946711671247,0.136648495146606,"HRAS/GRB2",2
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","2/87","23/2914",0.149021865112748,0.245946711671247,0.136648495146606,"PIK3CA/GRB2",2
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","2/87","23/2914",0.149021865112748,0.245946711671247,0.136648495146606,"HRAS/GRB2",2
"R-HSA-422356","R-HSA-422356","Regulation of insulin secretion","3/87","45/2914",0.149366683399708,0.245946711671247,0.136648495146606,"PRKACA/GNAQ/PRKCA",3
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","8/87","177/2914",0.155252987175027,0.254971616013294,0.141662750424925,"MAPK1/HRAS/MAP2K1/IRS1/EGFR/GRB2/PPP2CA/SRC",8
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/87","46/2914",0.156531455622567,0.256401785381757,0.142457355445977,"VDR/ESR1/RARA",3
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","2/87","24/2914",0.159561658153659,0.258670832419205,0.143718042612628,"BCL10/RELA",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/87","24/2914",0.159561658153659,0.258670832419205,0.143718042612628,"RB1/TP53",2
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/87","24/2914",0.159561658153659,0.258670832419205,0.143718042612628,"RHOA/PAK1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/87","24/2914",0.159561658153659,0.258670832419205,0.143718042612628,"STAT3/STAT5A",2
"R-HSA-69242","R-HSA-69242","S Phase","4/87","71/2914",0.160362661372277,0.259301064275482,0.144068200718701,"RB1/AKT1/AKT2/MAX",4
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/87","25/2914",0.170236231156731,0.271773069537014,0.150997672305729,"PRKACA/PLK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/87","25/2914",0.170236231156731,0.271773069537014,0.150997672305729,"PRKACA/PLK1",2
"R-HSA-5654700","R-HSA-5654700","FRS-mediated FGFR2 signaling","2/87","25/2914",0.170236231156731,0.271773069537014,0.150997672305729,"HRAS/GRB2",2
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2/87","25/2914",0.170236231156731,0.271773069537014,0.150997672305729,"EGFR/ESR1",2
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","2/87","25/2914",0.170236231156731,0.271773069537014,0.150997672305729,"AKT1/AKT2",2
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","3/87","48/2914",0.171174228053976,0.272578707458103,0.151445286379533,"MAPK8/VAV2/VAV3",3
"R-HSA-5663205","R-HSA-5663205","Infectious disease","6/87","126/2914",0.171910241052881,0.273059448541066,0.151712387106743,"CTNNB1/MAP2K1/MAP2K7/GRB2/SRC/TBP",6
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/87","49/2914",0.178640999021251,0.283035739003443,0.157255234455933,"MAPK1/SIRT1/MAPKAPK2",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/87","26/2914",0.181028425219199,0.283250943937502,0.157374802756674,"AKT1/AKT2",2
"R-HSA-182971","R-HSA-182971","EGFR downregulation","2/87","26/2914",0.181028425219199,0.283250943937502,0.157374802756674,"EGFR/GRB2",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/87","26/2914",0.181028425219199,0.283250943937502,0.157374802756674,"PRKACA/PLK1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/87","26/2914",0.181028425219199,0.283250943937502,0.157374802756674,"PRKACA/PLK1",2
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","2/87","26/2914",0.181028425219199,0.283250943937502,0.157374802756674,"PIK3CA/GRB2",2
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","15/87","393/2914",0.186519839125003,0.291119054118181,0.161746340837145,"BCL10/IKBKE/RELA/RIPK2/SMAD3/SMAD4/TP53/TRAF3/RHOA/PRKDC/VDR/ESR1/FOXO4/RARA/SMAD2",15
"R-HSA-165159","R-HSA-165159","mTOR signalling","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"AKT1/AKT2",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"PRKACA/PLK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"PRKACA/PLK1",2
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"RELA/RIPK2",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"JUN/RARA",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"JUN/RARA",2
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"BCL10/PRKDC",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"ABL1/YAP1",2
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","2/87","27/2914",0.191921964261921,0.293007076506671,0.162795329930909,"GRB2/SYK",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/87","28/2914",0.202901418616164,0.308272928283978,0.171277068346215,"PRKACA/PLK1",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/87","28/2914",0.202901418616164,0.308272928283978,0.171277068346215,"IKBKE/TBK1",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","3/87","53/2914",0.20934824864501,0.317301321440269,0.176293262016851,"CSNK2A1/CSNK2B/SRC",3
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/87","29/2914",0.213952169958461,0.321951949530795,0.178877160478996,"PLK1/PPP2CA",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/87","29/2914",0.213952169958461,0.321951949530795,0.178877160478996,"PLK1/PPP2CA",2
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","2/87","29/2914",0.213952169958461,0.321951949530795,0.178877160478996,"PRKCD/PRKCA",2
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","4/87","81/2914",0.221377335252912,0.332330176310458,0.184643324466692,"MAPK8/TP53/ABL1/PRKDC",4
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/87","30/2914",0.225060377546906,0.337054708278581,0.187268284074117,"CTNNB1/PPP2CA",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/87","31/2914",0.236212945713744,0.352916728869229,0.196081255099295,"CTNNB1/PPP2CA",2
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","3/87","57/2914",0.241142122989159,0.359427477156827,0.199698640140685,"RELA/RIPK2/MAP2K1",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","4/87","86/2914",0.253975102417172,0.377660376880381,0.209828876452659,"SMAD3/SMAD4/RHOA/SMAD2",4
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"MAP2K1",1
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"MAPK1",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"PRKCD",1
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"PIK3CA",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"RELA",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"CREB1",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"TBP",1
"R-HSA-8875360","R-HSA-8875360","InlB-mediated entry of Listeria monocytogenes into host cell","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"GRB2",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"STAT3",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/87","10/2914",0.261831075628069,0.380350453972415,0.211323488777243,"MAPK1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/87","34/2914",0.269816384083264,0.391047247899477,0.217266649322444,"PLK1/PPP2CA",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/87","61/2914",0.273695184105303,0.3933960526024,0.218571650010873,"CSNK2A1/CSNK2B/SRC",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/87","62/2914",0.281915894340619,0.3933960526024,0.218571650010873,"PRKACA/TP53/ABL1",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"STAT3",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"MAX",1
"R-HSA-163615","R-HSA-163615","PKA activation","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"PRKACA",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"RELA",1
"R-HSA-209543","R-HSA-209543","p75NTR recruits signalling complexes","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"RIPK2",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"SRC",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"CREB1",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"TP53",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"SRC",1
"R-HSA-5099900","R-HSA-5099900","WNT5A-dependent internalization of FZD4","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"PRKCA",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"TP53",1
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"TP53",1
"R-HSA-73772","R-HSA-73772","RNA Polymerase I Promoter Escape","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"TBP",1
"R-HSA-73863","R-HSA-73863","RNA Polymerase I Transcription Termination","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"TBP",1
"R-HSA-8875555","R-HSA-8875555","MET activates RAP1 and RAC1","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"GRB2",1
"R-HSA-8978868","R-HSA-8978868","Fatty acid metabolism","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"MAPKAPK2",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"STAT3",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/87","11/2914",0.283945640511112,0.3933960526024,0.218571650010873,"PIK3CA",1
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","2/87","36/2914",0.292231155776444,0.403985487875567,0.224455161868778,"GRB2/SRC",2
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/87","37/2914",0.303412803516553,0.408722957904351,0.227087309889121,"CTNNB1/PPP2CA",2
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/87","37/2914",0.303412803516553,0.408722957904351,0.227087309889121,"SIRT1/TBP",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/87","37/2914",0.303412803516553,0.408722957904351,0.227087309889121,"PRKACA/PLK1",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"CREB1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"CTNNB1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"PAK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"CTNNB1",1
"R-HSA-5362517","R-HSA-5362517","Signaling by Retinoic Acid","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"RARA",1
"R-HSA-5635838","R-HSA-5635838","Activation of SMO","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"CDON",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"RELA",1
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"PRKACA",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"PRKACA",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"PRKACA",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"CREB1",1
"R-HSA-975163","R-HSA-975163","IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation","1/87","12/2914",0.305405071884014,0.408722957904351,0.227087309889121,"TICAM1",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","2/87","38/2914",0.314565517938831,0.420088557926804,0.233402060466403,"BCL10/RELA",2
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","5/87","125/2914",0.316828286195582,0.422213966137757,0.234582941607791,"CSNK2B/MAPK1/MAPK14/PRKCD/RHOA",5
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"MAPK8",1
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"SRC",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PAK1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PPP2CA",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PPP2CA",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PPP2CA",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PPP2CA",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PPP2CA",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PPP2CA",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"TP53",1
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"EGFR",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"PAK1",1
"R-HSA-937072","R-HSA-937072","TRAF6-mediated induction of TAK1 complex within TLR4 complex","1/87","13/2914",0.326228558702102,0.422217620213214,0.234584971819575,"TICAM1",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","2/87","40/2914",0.336751975795724,0.433163584407996,0.240666571874244,"RELA/KLF4",2
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","2/87","40/2914",0.336751975795724,0.433163584407996,0.240666571874244,"CTNNB1/PRKCA",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/87","40/2914",0.336751975795724,0.433163584407996,0.240666571874244,"SMAD3/AKT1",2
"R-HSA-2173791","R-HSA-2173791","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"RHOA",1
"R-HSA-373753","R-HSA-373753","Nephrin family interactions","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"PIK3CA",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"CTNNB1",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"PAK1",1
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"MAP2K1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"E2F3",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"PPP2CA",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"SRC",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/87","14/2914",0.346434734294283,0.437565156367679,0.243112094241602,"PPP2CA",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/87","42/2914",0.358731078399245,0.446201985339091,0.247910734051675,"CTNNB1/KLF4",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/87","42/2914",0.358731078399245,0.446201985339091,0.247910734051675,"MAPK14/PPP2CA",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/87","42/2914",0.358731078399245,0.446201985339091,0.247910734051675,"PRKACA/PLK1",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/87","42/2914",0.358731078399245,0.446201985339091,0.247910734051675,"PLK1/PPP2CA",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/87","42/2914",0.358731078399245,0.446201985339091,0.247910734051675,"EGR1/IRF4",2
"R-HSA-1430728","R-HSA-1430728","Metabolism","10/87","289/2914",0.360027734322706,0.446201985339091,0.247910734051675,"CSNK2A1/CSNK2B/PRKACA/GNAQ/PIK3CA/AKT1/MAPKAPK2/PPP2CA/PRKCA/VDR",10
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"STAT5A",1
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"TICAM1",1
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"PIK3CA",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"PLK1",1
"R-HSA-392517","R-HSA-392517","Rap1 signalling","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"PRKACA",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"TBP",1
"R-HSA-442982","R-HSA-442982","Ras activation upon Ca2+ influx through NMDA receptor","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"HRAS",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"TBP",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"TP53",1
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"TP53",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/87","15/2914",0.366041692265454,0.446201985339091,0.247910734051675,"AKT1",1
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","2/87","44/2914",0.380450723874849,0.461346941382834,0.256325302550583,"RHOA/PRKCA",2
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","2/87","44/2914",0.380450723874849,0.461346941382834,0.256325302550583,"PRKACA/PPP2CA",2
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"TP53",1
"R-HSA-428930","R-HSA-428930","Thromboxane signalling through TP receptor","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"GNAQ",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"PAK1",1
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"TRAF3",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"RELA",1
"R-HSA-6807004","R-HSA-6807004","Negative regulation of MET activity","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"GRB2",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/87","16/2914",0.385067001949106,0.461346941382834,0.256325302550583,"SRC",1
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","4/87","106/2914",0.3907117267487,0.467219916587324,0.259588339564876,"RHOA/ARHGAP1/VAV2/VAV3",4
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","3/87","76/2914",0.397659261142646,0.470907120654671,0.261636957672749,"CTNNB1/RHOA/PRKCA",3
"R-HSA-163359","R-HSA-163359","Glucagon signaling in metabolic regulation","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"PRKACA",1
"R-HSA-167161","R-HSA-167161","HIV Transcription Initiation","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TBP",1
"R-HSA-167162","R-HSA-167162","RNA Polymerase II HIV Promoter Escape","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TBP",1
"R-HSA-168927","R-HSA-168927","TICAM1, RIP1-mediated IKK complex recruitment","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TICAM1",1
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"PRKCA",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"PRKCA",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"RELA",1
"R-HSA-73776","R-HSA-73776","RNA Polymerase II Promoter Escape","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TBP",1
"R-HSA-73779","R-HSA-73779","RNA Polymerase II Transcription Pre-Initiation And Promoter Opening","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TBP",1
"R-HSA-75953","R-HSA-75953","RNA Polymerase II Transcription Initiation","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TBP",1
"R-HSA-76042","R-HSA-76042","RNA Polymerase II Transcription Initiation And Promoter Clearance","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"TBP",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/87","17/2914",0.403527723422684,0.470907120654671,0.261636957672749,"SMAD3",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","2/87","47/2914",0.412446095024968,0.480423321797601,0.266924178456704,"PRKCD/IRF4",2
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"PIK3CA",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"PAK1",1
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"CASP3",1
"R-HSA-5610780","R-HSA-5610780","Degradation of GLI1 by the proteasome","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"PRKACA",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"PRKACA",1
"R-HSA-5658442","R-HSA-5658442","Regulation of RAS by GAPs","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"HRAS",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/87","18/2914",0.421440422097943,0.484617962522132,0.269254729407326,"MAX",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","5/87","144/2914",0.431605394498258,0.495401082371176,0.275245852811029,"AKT1/AKT2/EGFR/GRB2/SRC",5
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","1/87","19/2914",0.438821182898178,0.498228382749014,0.276816706673371,"MAX",1
"R-HSA-2514856","R-HSA-2514856","The phototransduction cascade","1/87","19/2914",0.438821182898178,0.498228382749014,0.276816706673371,"PRKCA",1
"R-HSA-2514859","R-HSA-2514859","Inactivation, recovery and regulation of the phototransduction cascade","1/87","19/2914",0.438821182898178,0.498228382749014,0.276816706673371,"PRKCA",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/87","19/2914",0.438821182898178,0.498228382749014,0.276816706673371,"CTNNB1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/87","19/2914",0.438821182898178,0.498228382749014,0.276816706673371,"PRKACA",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/87","19/2914",0.438821182898178,0.498228382749014,0.276816706673371,"TBP",1
"R-HSA-5578775","R-HSA-5578775","Ion homeostasis","1/87","20/2914",0.45568562403388,0.512748224539017,0.284883960416624,"PRKACA",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/87","20/2914",0.45568562403388,0.512748224539017,0.284883960416624,"TBP",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/87","20/2914",0.45568562403388,0.512748224539017,0.284883960416624,"TBP",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/87","20/2914",0.45568562403388,0.512748224539017,0.284883960416624,"EGFR",1
"R-HSA-937041","R-HSA-937041","IKK complex recruitment mediated by RIP1","1/87","20/2914",0.45568562403388,0.512748224539017,0.284883960416624,"TICAM1",1
"R-HSA-400253","R-HSA-400253","Circadian Clock","2/87","52/2914",0.463915283602802,0.521076273903862,0.289511041646861,"SIRT1/CREB1",2
"R-HSA-397014","R-HSA-397014","Muscle contraction","2/87","53/2914",0.473898304581539,0.529599118586678,0.294246351553472,"PRKACA/PAK1",2
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","2/87","53/2914",0.473898304581539,0.529599118586678,0.294246351553472,"EGFR/GRB2",2
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","7/87","217/2914",0.47402909978426,0.529599118586678,0.294246351553472,"MAPK1/PRKACA/PRKCD/PPP2CA/PRKCA/SRC/CREB1",7
"R-HSA-167172","R-HSA-167172","Transcription of the HIV genome","1/87","22/2914",0.487925766522278,0.539376638211797,0.299678761419658,"TBP",1
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","1/87","22/2914",0.487925766522278,0.539376638211797,0.299678761419658,"CTNNB1",1
"R-HSA-432040","R-HSA-432040","Vasopressin regulates renal water homeostasis via Aquaporins","1/87","22/2914",0.487925766522278,0.539376638211797,0.299678761419658,"PRKACA",1
"R-HSA-445717","R-HSA-445717","Aquaporin-mediated transport","1/87","22/2914",0.487925766522278,0.539376638211797,0.299678761419658,"PRKACA",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/87","22/2914",0.487925766522278,0.539376638211797,0.299678761419658,"TP53",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/87","22/2914",0.487925766522278,0.539376638211797,0.299678761419658,"TP53",1
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/87","55/2914",0.49353103415424,0.544615825408802,0.302589664523006,"PRKACA/CDON",2
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/87","56/2914",0.503176255293355,0.549643885031713,0.305383264715135,"PLK1/PPP2CA",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/87","23/2914",0.50333048931362,0.549643885031713,0.305383264715135,"SMAD4",1
"R-HSA-3000170","R-HSA-3000170","Syndecan interactions","1/87","23/2914",0.50333048931362,0.549643885031713,0.305383264715135,"PRKCA",1
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","1/87","23/2914",0.50333048931362,0.549643885031713,0.305383264715135,"ABL1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/87","23/2914",0.50333048931362,0.549643885031713,0.305383264715135,"STAT3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/87","23/2914",0.50333048931362,0.549643885031713,0.305383264715135,"E2F3",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/87","24/2914",0.518276960233618,0.564984762542367,0.313906687581066,"TP53",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","5/87","160/2914",0.525610987977242,0.571988428092881,0.317797938460106,"AKT1/AKT2/EGFR/GRB2/SRC",5
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/87","60/2914",0.540574160340622,0.587255866760365,0.326280558554834,"PLK1/PPP2CA",2
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/87","26/2914",0.54684866656086,0.592027213884305,0.328931528758412,"TBP",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/87","26/2914",0.54684866656086,0.592027213884305,0.328931528758412,"ESR1",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/87","61/2914",0.549620905297752,0.594006098680903,0.330031001191632,"PLK1/PPP2CA",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","3/87","97/2914",0.559717112492731,0.602656935482074,0.334837423780518,"PRKCD/EGR1/IRF4",3
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/87","27/2914",0.560499693572358,0.602656935482074,0.334837423780518,"PRKDC",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/87","27/2914",0.560499693572358,0.602656935482074,0.334837423780518,"SRC",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/87","28/2914",0.573744074126291,0.613750038478634,0.341000774453864,"PLK1",1
"R-HSA-381676","R-HSA-381676","Glucagon-like Peptide-1 (GLP1) regulates insulin secretion","1/87","28/2914",0.573744074126291,0.613750038478634,0.341000774453864,"PRKACA",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/87","28/2914",0.573744074126291,0.613750038478634,0.341000774453864,"VDR",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/87","29/2914",0.586593784989428,0.626430374801952,0.348045995204164,"CREB1",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","2/87","66/2914",0.592992600545277,0.632190416513525,0.351246286139219,"EGFR/GRB2",2
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/87","30/2914",0.599060454211584,0.635428373860179,0.353045301851861,"PLK1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/87","30/2914",0.599060454211584,0.635428373860179,0.353045301851861,"TP53",1
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","1/87","30/2914",0.599060454211584,0.635428373860179,0.353045301851861,"TP53",1
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","1/87","31/2914",0.611155371161512,0.644994510839917,0.3583602670887,"PRKACA",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/87","31/2914",0.611155371161512,0.644994510839917,0.3583602670887,"AKT1",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/87","31/2914",0.611155371161512,0.644994510839917,0.3583602670887,"RELA",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/87","32/2914",0.622889496277345,0.655179754445569,0.364019209230908,"CREB1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/87","32/2914",0.622889496277345,0.655179754445569,0.364019209230908,"STAT3",1
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","1/87","33/2914",0.634273470539618,0.666040088429749,0.370053232965738,"CDON",1
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/87","34/2914",0.645317624674659,0.676507976533935,0.375869212968398,"PLK1",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/87","35/2914",0.656031988095946,0.684318607814842,0.380208815654803,"CTNNB1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/87","35/2914",0.656031988095946,0.684318607814842,0.380208815654803,"PRKACA",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/87","35/2914",0.656031988095946,0.684318607814842,0.380208815654803,"PRKACA",1
"R-HSA-2187338","R-HSA-2187338","Visual phototransduction","1/87","36/2914",0.666426297590789,0.694010167524182,0.385593466016281,"PRKCA",1
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","3/87","114/2914",0.670392537296551,0.696986621420711,0.387247189878129,"TP53/PLK1/PPP2CA",3
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/87","37/2914",0.676510005759517,0.702186128090324,0.390136046399444,"EGFR",1
"R-HSA-73894","R-HSA-73894","DNA Repair","4/87","157/2914",0.699710016150932,0.725070181480949,0.402850473184964,"MAPK8/TP53/ABL1/PRKDC",4
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/87","40/2914",0.704987956049534,0.728140269877104,0.404556220565976,"PLK1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/87","40/2914",0.704987956049534,0.728140269877104,0.404556220565976,"PLK1",1
"R-HSA-162599","R-HSA-162599","Late Phase of HIV Life Cycle","1/87","42/2914",0.722581488264021,0.743868667951014,0.41329495064804,"TBP",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/87","42/2914",0.722581488264021,0.743868667951014,0.41329495064804,"STAT3",1
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","1/87","45/2914",0.747044836169992,0.767796081619158,0.426589070533948,"TRAF3",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/87","46/2914",0.754715487704746,0.774414423762293,0.430266234941145,"TP53",1
"R-HSA-3000171","R-HSA-3000171","Non-integrin membrane-ECM interactions","1/87","49/2914",0.776374444447135,0.795341246835908,0.441893220566516,"PRKCA",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/87","51/2914",0.78975198040477,0.807730074267643,0.448776478381487,"E2F3",1
"R-HSA-162587","R-HSA-162587","HIV Life Cycle","1/87","53/2914",0.802337908910611,0.819270364780478,0.455188287351884,"TBP",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/87","59/2914",0.835796097617986,0.852051451218336,0.473401525904925,"ABL1",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","1/87","62/2914",0.850359537507822,0.864097171393247,0.480094152627492,"TP53",1
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","1/87","62/2914",0.850359537507822,0.864097171393247,0.480094152627492,"PRKCA",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/87","63/2914",0.854924306174309,0.867334497715548,0.481892817741716,"ABL1",1
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","1/87","70/2914",0.883243905333785,0.894622248719728,0.497053947912224,"CASP3",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/87","73/2914",0.893637970096484,0.903694989052554,0.502094780964686,"SRC",1
"R-HSA-162906","R-HSA-162906","HIV Infection","1/87","80/2914",0.914466949041951,0.923274014361777,0.512972927400401,"TBP",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/87","88/2914",0.933370227148778,0.940849155250932,0.522737711561057,"CBLB",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","2/87","157/2914",0.954153221825175,0.960259802444856,0.53352230677214,"CASP3/PRKCA",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/87","109/2914",0.965528867158342,0.968608704055178,0.538160973552538,"RELA",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/87","109/2914",0.965528867158342,0.968608704055178,0.538160973552538,"RELA",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/87","115/2914",0.971471388179745,0.973018317141815,0.540610963586449,"CBLB",1
"R-HSA-382551","R-HSA-382551","Transport of small molecules","1/87","121/2914",0.976399206870248,0.976399206870248,0.542489392822228,"PRKACA",1
